Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer
Damien Zanker, Katie L. Owen, Nikola Baschuk, Alex Spurling, Belinda S. Parker
Topics & Concepts
Cancer researchImmune systemCytotoxic T cellImmunologyBiologyCarcinogenesisDegranulationSignal transductionBreast cancerImmunotherapyCancerMedicineReceptorInternal medicineCell biologyIn vitroBiochemistryImmune Cell Function and InteractionT-cell and B-cell ImmunologyImmune cells in cancer